Ultragenyx Pharmaceutical (RARE) Q2 2026 Earnings

30AprConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-1.81
-1.57
-1.33
-1.09

Details

Expected EPS
-1.429941
Actual EPS
N/A
Surprise EPS
1.43
Surprise Percent
+100%

Description

Ultragenyx Pharmaceutical (RARE) will report earnings of for Q2 2026 on April 30, 2026.

0 Comments

Share your thoughts